Comparator Enalapril


Combined with:

Aliskiren
Blinded Aliskiren Ali+Tab+CF
Blinded Enalapril Comp-Ena+
Blinded NO Treatment Received Nomed

Indications and Reactions:

Role Indications Reactions
Primary
Cardiac Failure 100.0%
Palpitations 100.0%
Secondary
Cardiac Failure 63.3%
Cardiac Failure Chronic 10.4%
Diabetes Mellitus 3.9%
Cardiac Failure Congestive 3.7%
Hyperuricaemia 3.2%
Glaucoma 2.2%
Atrial Fibrillation 1.8%
Cerebral Artery Embolism 1.6%
Chronic Obstructive Pulmonary Disease 1.1%
Hypothyroidism 1.0%
Constipation 0.9%
Hypertension 0.9%
Ventricular Extrasystoles 0.9%
Dizziness 0.9%
Cerebral Infarction 0.8%
Ventricular Fibrillation 0.7%
Myocardial Ischaemia 0.7%
Myocardial Infarction 0.7%
Prophylaxis 0.7%
Hyperlipidaemia 0.6%
Weight Increased 10.7%
Vomiting 9.4%
Urinary Tract Infection 8.6%
Dyspnoea 8.2%
Pulmonary Oedema 6.4%
Renal Impairment 6.4%
Vertigo 6.4%
Cardiac Failure 5.2%
Scar 5.2%
Ventricular Tachycardia 4.3%
General Physical Health Deterioration 3.9%
Hypotension 3.4%
Renal Failure 3.4%
Urinary Incontinence 3.4%
Orthopnoea 3.0%
Abdominal Pain 2.6%
Coronary Artery Disease 2.6%
Death 2.6%
Acute Abdomen 2.1%
Oedema 2.1%

Drug Data